Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03422393
Brief Title: Venetoclax With High-dose Ibrutinib for the Treatment of Patients With Chronic Lymphocytic Leukemia With Progressive Disease on Single Agent Ibrutinib

First Submitted : January 30, 2018
First Submitted that Met QC Criteria : January 30, 2018
First Posted : February 5, 2018

Last Update Submitted that Met QC Criteria : January 23, 2019
Last Update Posted : January 25, 2019